28451474|t|Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
28451474|a|Thymic carcinoid tumors are very rare. Between two and four percent of carcinoids originate from the thymus with an estimated incidence of 1.5 to 3 per 10,000,000 persons per year. Thymic carcinoids can be associated with the multiple endocrine neoplasia (MEN) type 1. The principal treatment is surgical resection. The potential roles of systemic and radiation treatments are a matter of debate. We describe the successful multidisciplinary treatment of a case of thymic carcinoid associated with MEN and review the literature pertaining to the use of adjuvant thoracic radiation.
28451474	0	21	Adjuvant Radiotherapy	T061	C0242939
28451474	26	54	Thymic Neuroendocrine Tumors	T191	C2210965
28451474	58	69	Case Report	T170	C0007320
28451474	74	98	Review of the Literature	T170	C0282441
28451474	99	122	Thymic carcinoid tumors	T191	C2210965
28451474	132	136	rare	T080	C0522498
28451474	170	180	carcinoids	T191	C0007095
28451474	181	190	originate	T079	C0439659
28451474	200	206	thymus	T023	C0040113
28451474	215	224	estimated	T081	C0750572
28451474	225	234	incidence	T081	C0021149
28451474	262	269	persons	T098	C0027361
28451474	270	278	per year	T079	C0439508
28451474	280	297	Thymic carcinoids	T191	C1336746
28451474	305	320	associated with	T080	C0332281
28451474	325	366	multiple endocrine neoplasia (MEN) type 1	T191	C0025267
28451474	372	381	principal	T080	C0205225
28451474	382	391	treatment	T169	C1522326
28451474	395	413	surgical resection	T061	C0728940
28451474	419	428	potential	T080	C3245505
28451474	438	446	systemic	T169	C0205373
28451474	451	471	radiation treatments	T061	C3871222
28451474	512	522	successful	T080	C1272703
28451474	523	550	multidisciplinary treatment	T061	C0870721
28451474	556	560	case	T077	C1706256
28451474	564	580	thymic carcinoid	T191	C2210965
28451474	581	596	associated with	T080	C0332281
28451474	597	600	MEN	T191	C0027662
28451474	605	626	review the literature	T170	C0282441
28451474	652	679	adjuvant thoracic radiation	T061	C0242939